349 related articles for article (PubMed ID: 14568813)
1. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
[TBL] [Abstract][Full Text] [Related]
2. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
3. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
[TBL] [Abstract][Full Text] [Related]
4. [Facioscapuloperoneal muscular dystrophy: correlation between a phenotype and genotype].
Rudenko DI; Kazakov BM; Skoromets AA; Magomedova NK
Patol Fiziol Eksp Ter; 2009; (2):22-7. PubMed ID: 19537084
[TBL] [Abstract][Full Text] [Related]
5. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
[TBL] [Abstract][Full Text] [Related]
7. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
[TBL] [Abstract][Full Text] [Related]
8. FSHD-like patients without 4q35 deletion.
Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
[TBL] [Abstract][Full Text] [Related]
9. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
Su Q; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
[TBL] [Abstract][Full Text] [Related]
10. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
12. [Facioscapulohumeral muscular dystrophy (FSHD)].
Funakoshi M; Goto K; Kim BY; Arahata K
Nihon Rinsho; 1997 Dec; 55(12):3181-5. PubMed ID: 9436432
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
Upadhyaya M; Cooper DN
Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity in a South African patient with facioscapulohumeral muscular dystrophy.
Olckers A; van der Merwe A; Wayne Towers G; Retief CF; Honey E; Schutte CM
Neuromuscul Disord; 2012 Aug; 22(8):728-34. PubMed ID: 22652079
[TBL] [Abstract][Full Text] [Related]
15. Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions.
Trevisan CP; Pastorello E; Tomelleri G; Vercelli L; Bruno C; Scapolan S; Siciliano G; Comacchio F
Eur J Neurol; 2008 Dec; 15(12):1353-8. PubMed ID: 19049553
[TBL] [Abstract][Full Text] [Related]
16. A severe case of facioscapulohumeral muscular dystrophy (FSHD) with some uncommon clinical features and a short 4q35 fragment.
Dorobek M; Kabzińska D
Eur J Paediatr Neurol; 2004; 8(6):313-6. PubMed ID: 15542386
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD).
Wood-Allum C; Brennan P; Hewitt M; Lowe J; Tyfield L; Wills A
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):188-91. PubMed ID: 15043716
[No Abstract] [Full Text] [Related]
18. Infantile facioscapulohumeral muscular dystrophy revisited: Expansion of clinical phenotypes in patients with a very short EcoRI fragment.
Chen TH; Lai YH; Lee PL; Hsu JH; Goto K; Hayashi YK; Nishino I; Lin CW; Shih HH; Huang CC; Liang WC; Wang WF; Jong YJ
Neuromuscul Disord; 2013 Apr; 23(4):298-305. PubMed ID: 23434070
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy].
Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821
[TBL] [Abstract][Full Text] [Related]
20. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
Goto K; Nishino I; Hayashi YK
Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]